|
MEAF6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.36459999545391E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.50120000000009E-05 |
| Normal-vs-Stage2 |
2.302700E-03 |
| Normal-vs-Stage3 |
3.36669999989603E-07 |
| Normal-vs-Stage4 |
2.18509999982963E-07 |
| Stage1-vs-Stage2 |
7.357000E-01 |
| Stage1-vs-Stage3 |
4.739900E-02 |
| Stage1-vs-Stage4 |
2.298400E-02 |
| Stage2-vs-Stage3 |
3.299200E-01 |
| Stage2-vs-Stage4 |
2.182800E-01 |
| Stage3-vs-Stage4 |
6.543000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.43610000452799E-08 |
| Normal-vs-AfricanAmerican |
1.259570E-03 |
| Normal-vs-Asian |
7.935000E-01 |
| Caucasian-vs-AfricanAmerican |
7.292000E-01 |
| Caucasian-vs-Asian |
1.740400E-01 |
| AfricanAmerican-vs-Asian |
8.555600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47260000252325E-08 |
| Normal-vs-Female |
1.017170E-04 |
| Male-vs-Female |
6.540100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.722500E-03 |
| Normal-vs-Age(41-60Yrs) |
2.64490000001505E-06 |
| Normal-vs-Age(61-80Yrs) |
8.73600000006469E-07 |
| Normal-vs-Age(81-100Yrs) |
6.36419999999749E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.813600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.771000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.808170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.852800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.303700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.105700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.371400E-01 |
| Normal-vs-Grade 2 |
2.144500E-03 |
| Normal-vs-Grade 3 |
5.37930000543696E-09 |
| Normal-vs-Grade 4 |
3.07419978362589E-10 |
| Grade 1-vs-Grade 2 |
2.077000E-01 |
| Grade 1-vs-Grade 3 |
2.440500E-03 |
| Grade 1-vs-Grade 4 |
4.842900E-04 |
| Grade 2-vs-Grade 3 |
2.628500E-04 |
| Grade 2-vs-Grade 4 |
1.26800000055383E-07 |
| Grade 3-vs-Grade 4 |
1.818090E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.738000E-03 |
| Normal-vs-ccB subtype |
1.04849999793544E-08 |
| ccA subtype-vs-ccB subtype |
1.67589999999773E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.49069999963747E-07 |
| Normal-vs-N1 |
1.400100E-02 |
| N0-vs-N1 |
9.194400E-01 |
|
|
